Liver Stiffness clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18 years and up
The primary objective of this study is to evaluate the effect of setanaxib on biochemical response at Week 52 in participants with primary biliary cholangitis (PBC) and with elevated liver stiffness and intolerance or inadequate response to ursodeoxycholic acid (UDCA).
at UC Davis